Experiences with Dicumarol in Acute Myocardial Infarction

Publisher Website
Google Scholar
Abstract
NUMEROUS reports1 2 3 4 5 6 during the past few years have emphasized the value of Dicumarol therapy in reducing the mortality rate and the incidence of thromboembolic complications following acute myocardial infarction. These series have in general represented carefully followed cases under the direct supervision of well organized research teams, and results as reported have been favorable. Consequently, the statement has been made that Dicumarol therapy is indicated in every case of myocardial infarction in which proper laboratory facilities are available.However, modes of therapy that work well under research conditions may not be so successful under the conditions of average hospital practice. . . .